Biotron Limited (BIT.AX)
AUD 0.02
(-5.88%)
AUD 0.02
(-5.88%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | 1.43 Million | 1.55 Million | 1.46 Million | 803.02 Thousand | 1.07 Million |
| Cost of Revenue | 40.49 Thousand | 43.34 Thousand | 45.25 Thousand | 47.33 Thousand | 50.11 Thousand | 12.46 Thousand |
| Gross Profit | -40.49 Thousand | 1.38 Million | 1.51 Million | 1.41 Million | 752.9 Thousand | 1.06 Million |
| Operating Expenses | 5.11 Million | 4.99 Million | 2.73 Million | 4.26 Million | 3.99 Million | 2.76 Million |
| Selling, General and Administrative Expenses | 1.39 Million | 1.62 Million | 1.11 Million | 1.13 Million | 1.14 Million | 1.64 Million |
| Research and Development Expenses | 3.62 Million | 3.23 Million | 2.82 Million | 3.13 Million | 2.85 Million | 1.11 Million |
| Other Expenses | -89.99 Thousand | -136.89 Thousand | 1.2 Million | 1.46 Million | 803.02 Thousand | 1.07 Million |
| Cost and Expenses | 5.15 Million | 5.03 Million | 2.77 Million | 4.31 Million | 4.04 Million | 2.77 Million |
| Operating Income | -5.15 Million | -5.03 Million | -2.77 Million | -4.31 Million | -4.04 Million | -2.77 Million |
| Interest Expense | 1086.00 | 4389.00 | 5049.00 | 1261.00 | 5118.00 | - |
| Income Tax Expense | -1.64 Million | -1.43 Million | 5.00 | -1.41 Million | -753.02 Thousand | -1.07 Million |
| Earnings before Tax | -5.08 Million | -4.92 Million | -2.78 Million | -4.6 Million | -4.32 Million | -2.68 Million |
| Net Income | -3.43 Million | -3.49 Million | -2.78 Million | -3.19 Million | -3.57 Million | -1.61 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 |
| Weighted Average Shares Outstanding | 902.17 Million | 820.84 Million | 724.78 Million | 724.78 Million | 675.46 Million | 577.49 Million |
| Weighted Average Shares Outstanding (Diluted) | 902.17 Million | 820.84 Million | 724.78 Million | 724.78 Million | 675.46 Million | 577.49 Million |
| Gross Margin | - | 0.97 | 0.97 | 0.97 | 0.94 | 0.99 |
| EBIT Margin | - | -3.49 | -1.75 | -2.92 | -4.98 | -2.57 |
| Profit Margin | - | -2.44 | -1.78 | -2.18 | -4.45 | -1.50 |
| EBITDA | -5.04 Million | -4.87 Million | -2.73 Million | -4.55 Million | -4.27 Million | -2.67 Million |
| Earnings Before Tax Margin | - | -3.52 | -1.78 | -2.95 | -5.04 | -2.59 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.64 Million | 1.43 Million | - | 1.43 Million |
| Cost of Revenue | 40.49 Thousand | 18.79 Thousand | 21.7 Thousand | 43.34 Thousand | 20.82 Thousand | 22.51 Thousand |
| Gross Profit | -40.49 Thousand | -18.79 Thousand | 1.62 Million | 1.38 Million | -20.82 Thousand | 1.4 Million |
| Operating Expenses | 5.11 Million | 2.11 Million | 2.94 Million | 4.99 Million | 2.76 Million | 2.14 Million |
| Selling, General and Administrative Expenses | - | 648.62 Thousand | 747.19 Thousand | - | 693.49 Thousand | 932.66 Thousand |
| Research and Development Expenses | - | 1.42 Million | 2.19 Million | - | 2.01 Million | 1.21 Million |
| Other Expenses | -89.99 Thousand | -40.22 Thousand | - | -136.89 Thousand | -57.56 Thousand | - |
| Cost and Expenses | 5.15 Million | 2.13 Million | 2.96 Million | 5.03 Million | 2.78 Million | 2.16 Million |
| Operating Income | -5.15 Million | -2.13 Million | -2.96 Million | -5.03 Million | -2.78 Million | -2.16 Million |
| Interest Expense | 1086.00 | 532.00 | 554.00 | 4389.00 | 1768.00 | 2621.00 |
| Income Tax Expense | -1.64 Million | 4.00 | -1.64 Million | -1.43 Million | 2.00 | -1.43 Million |
| Earnings before Tax | -5.08 Million | -2.11 Million | -2.96 Million | -4.92 Million | -2.69 Million | -2.22 Million |
| Net Income | -3.43 Million | -2.11 Million | -1.32 Million | -3.49 Million | -2.69 Million | -793.58 Thousand |
| Earnings Per Share Basic | - | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 902.17 Million | 902.27 Million | 902.06 Million | 820.84 Million | 901.94 Million | 741.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 902.17 Million | 902.27 Million | 902.06 Million | 820.84 Million | 901.94 Million | 741.06 Million |
| Gross Margin | - | - | 0.99 | 0.97 | - | 0.98 |
| EBIT Margin | - | - | -1.79 | - | - | -1.50 |
| Profit Margin | - | - | -0.80 | -2.44 | - | -0.55 |
| EBITDA | - | -2.11 Million | -2.94 Million | - | -2.76 Million | -2.14 Million |
| Earnings Before Tax Margin | - | - | -1.80 | -3.52 | - | -1.52 |
PRG
MEDICAPQ
9325
605339
TRS
ATNFW